{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:11:30Z","timestamp":1790745090301,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T00:00:00Z","timestamp":1399420800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0096990","type":"journal-article","created":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T20:41:25Z","timestamp":1399495285000},"page":"e96990","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Real-World Efficiency of Pharmacogenetic Screening for Carbamazepine-Induced Severe Cutaneous Adverse Reactions"],"prefix":"10.1371","volume":"9","author":[{"given":"Zhibin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,5,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"T Glauser","year":"2013","journal-title":"Epilepsia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.49.2.542","article-title":"Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study","volume":"49","author":"P Tennis","year":"1997","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/WCO.0b013e328328f276","article-title":"Genetic basis for idiosyncratic reactions to antiepileptic drugs","volume":"22","author":"D Franciotta","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"JC Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Tangamornsuksan W, Chaiyakunapruk N, Somkrua R, Lohitnavy M, Tassaneeyakul W (2013) Relationship Between the HLA-B*15:02 Allele and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis. JAMA Dermatol.","DOI":"10.1001\/jamadermatol.2013.4114"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"WH Chung","year":"2004","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"SI Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*15:02 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese","volume":"48","author":"CB Man","year":"2007","journal-title":"Epilepsia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-4632.2010.04745.x","article-title":"Association of HLA-B*15:02 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population","volume":"50","author":"CC Chang","year":"2011","journal-title":"Int J Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B*15:02 screening in Taiwan","volume":"364","author":"P Chen","year":"2011","journal-title":"N Engl J Med"},{"key":"ref11","unstructured":"US Food and Drug Administration (2007) Information for Healthcare Professionals: Dangerous or Even Fatal Skin Reactions - Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, and generics). US Food and Drug Administration. Available: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketdrugsafetyinformationforPatientsandProviders\/ucm124718.htm<\/ext-link>. Accessed 18 November 2013."},{"key":"ref12","unstructured":"UK Medicines and Healthcare products Regulatory Agency (2008) Carbamazepine: genetic testing recommended in some Asian populations. Available: http:\/\/www.mhra.gov.uk\/Safetyinformation\/DrugSafetyUpdate\/CON084888<\/ext-link>. Accessed 18 November 2013."},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Leckband SG, Kelsoe JR, Dunnenberger HM, George AL, Jr., Tran E, et al<\/etal>.. (2013) Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing. Clin Pharmacol Ther.","DOI":"10.1038\/clpt.2013.103"},{"key":"ref14","first-page":"1183","article-title":"The Hong Kong Hospital Authority\u2019s information architecture","volume":"107","author":"NT Cheung","year":"2004","journal-title":"Stud Health Technol Inform"},{"key":"ref15","unstructured":"Hong Kong Hospital Authority Clusters, Hospitals & Institutions. Available: http:\/\/www.ha.org.hk\/visitor\/ha_visitor_index.asp?Content_ID=10036&Lang=ENG&Dimension=100&Parent_ID=10004<\/ext-link>. Accessed 18 November 2013."},{"key":"ref16","unstructured":"Census and Statistics Department HKSAR (2012) 2011 Population Census. Thematic Report: Ethnic Minorities. Census and Statistics Department, Hong Kong Special Administrative Region Government. Available: http:\/\/www.census2011.gov.hk\/pdf\/EM.pdf<\/ext-link>. Accessed 18 November 2013."},{"key":"ref17","unstructured":"Ng M, Ng H Re: Genetic testing prior to prescription of carbamazepine. Available: http:\/\/www.cuhk.edu.hk\/med\/paf\/ups\/HLA-B-15:02.pdf<\/ext-link>. Accessed 18 November 2013."},{"key":"ref18","first-page":"609","article-title":"Structured data entry of clinical information for documentation and data collection","volume":"84","author":"NT Cheung","year":"2001","journal-title":"Stud Health Technol Inform"},{"key":"ref19","unstructured":"Hong Kong Hospital Authority Fees and Charges. Available: http:\/\/www.ha.org.hk\/visitor\/ha_visitor_index.asp?Content_ID=10045&Lang=ENG&Dimension=100&Parent_ID=10044<\/ext-link>. Accessed 18 November 2013."},{"key":"ref20","unstructured":"Hong Kong Monetary Authority Linked Exchange Rate System. Available: http:\/\/www.hkma.gov.hk\/eng\/key-functions\/monetary-stability\/linked-exchange-rate-system.shtml<\/ext-link>. Accessed 18 November 2013."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/epi.12217","article-title":"HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese","volume":"54","author":"YK Cheung","year":"2013","journal-title":"Epilepsia"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jocn.2010.12.054","article-title":"Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions","volume":"18","author":"C Locharernkul","year":"2011","journal-title":"J Clin Neurosci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1258\/jms.2010.010033","article-title":"Breast and cervical cancer screening programme implementation in 16 countries","volume":"17","author":"EC Dowling","year":"2010","journal-title":"J Med Screen"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"JC Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJMcp1101540","article-title":"Clinical practice. Breast-cancer screening","volume":"365","author":"E Warner","year":"2011","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/bmj.326.7395.901","article-title":"Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented","volume":"326","author":"AE Raffle","year":"2003","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1212\/WNL.0b013e31826aac73","article-title":"Cost-effectiveness of HLA-B*15:02 genotyping in adult patients with newly diagnosed epilepsy in Singapore","volume":"79","author":"D Dong","year":"2012","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Rattanavipapong W, Koopitakkajorn T, Praditsitthikorn N, Mahasirimongkol S, Teerawattananon Y (2013) Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. Epilepsia.","DOI":"10.1111\/epi.12325"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11096-013-9777-9","article-title":"Cost minimization of HLA-B*15:02 screening before prescribing carbamazepine in Thailand","volume":"35","author":"S Tiamkao","year":"2013","journal-title":"Int J Clin Pharm"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1001\/jama.295.20.2374","article-title":"Cost-effectiveness of screening BRCA1\/2 mutation carriers with breast magnetic resonance imaging","volume":"295","author":"SK Plevritis","year":"2006","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, et al<\/etal>.. (2004) Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technol Assess 8: iii, 1\u201378.","DOI":"10.3310\/hta8200"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(12)60161-5","article-title":"Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial","volume":"379","author":"JD Roberts","year":"2012","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"T Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1525-1470.1984.tb01133.x","article-title":"Blindness, anonychia, and oral mucosal scarring as sequelae of the Stevens-Johnson syndrome","volume":"1","author":"RC Hansen","year":"1984","journal-title":"Pediatr Dermatol"},{"key":"ref35","unstructured":"Wallack T, Lazar K (Februray 13, 2013) Family awarded $63 million in Motrin case. The Boston Globe. Boston, MA."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0096990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T08:19:40Z","timestamp":1565425180000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0096990"}},"subtitle":[],"editor":[{"given":"Ryouhei","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,7]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0096990","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,7]]}}}